References
- Morens DM, Daszak P, Taubenberger JK. Escaping pandora’s box - another novel coronavirus. N Engl J Med. 2020;382(14):1293–1295. doi:10.1056/NEJMp2002106.
- Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369(6499):77–81. doi:10.1126/science.abc1932.
- Xia S, Zhang Y, Wang Y, et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial. Lancet Infect Dis. 2022;22(2):196–208. doi:10.1016/S1473-3099(21)00462-X.
- Bolletta E, Iannetta D, Mastrofilippo V, et al. Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med. 2021;10(24):5960. doi:10.3390/jcm10245960.
- ElSheikh RH, Haseeb A, Eleiwa TK, Elhusseiny AM. Acute uveitis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(6):1207–1209. doi:10.1080/09273948.2021.1962917.
- Jain A, Kalamkar C. COVID-19 vaccine-associated reactivation of uveitis. Indian J Ophthalmol. 2021;69(10):2899–2900. doi:10.4103/ijo.IJO_1435_21.
- Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G. Acute macular neuroretinopathy following coronavirus disease 2019 vaccination. Ocul Immunol Inflamm. 2021;29:1–4. doi:10.1080/09273948.2021.1946567.
- Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm. 2021;29:1–2. doi:10.1080/09273948.2021.1949478.
- Ng XL, Betzler BK, Testi I, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(6):1216–1224. doi:10.1080/09273948.2021.1976221.
- Pan L, Zhang Y, Cui Y, Wu X. Bilateral uveitis after inoculation with COVID-19 vaccine: a case report. Int J Infect Dis. 2021;113:116–118. doi:10.1016/j.ijid.2021.09.075.
- Cunningham ET Jr., Moorthy RS. Vaccine-associated posterior uveitis. Retina. 2020;40(4):595–598. doi:10.1097/IAE.0000000000002816.
- Cunningham ET Jr., Moorthy RS, Fraunfelder FW, Zierhut M. Vaccine-associated uveitis. Ocul Immunol Inflamm. 2019;27(4):517–520. doi:10.1080/09273948.2019.1626188.
- Eleiwa TK, Gaier ED, Haseeb A, ElSheikh RH, Sallam AB, Elhusseiny AM. Adverse ocular events following COVID-19 vaccination. Inflamm Res. 2021;70(10–12):1005–1009. doi:10.1007/s00011-021-01506-6.
- Testi I, Brandão-de-Resende C, Agrawal R, et al. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022;12(1):4. doi:10.1186/s12348-021-00275-x.
- Jabs DA, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516.
- Eichinger S, Warkentin TE, Greinacher A. Thrombotic thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Reply. N Engl J Med. 2021;385:e11.
- Gattringer T, Gressenberger P, Gary T, Wölfler A, Kneihsl M, Raggam RB. Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination. Stroke Vasc Neurol. 2022;7(1):86–88. doi:10.1136/svn-2021-001142.
- Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–2101. doi:10.1056/NEJMoa2104840.
- Agarwal M, Dutta Majumder P, Babu K, et al. Drug-induced uveitis: a review. Indian J Ophthalmol. 2020;68(9):1799–1807. doi:10.4103/ijo.IJO_816_20.
- Benage M, Fraunfelder FW. Vaccine-associated uveitis. Mo Med. 2016;113:48–52.
- Biancardi AL, Moraes HV Jr. Anterior and intermediate uveitis following yellow fever vaccination with fractional dose: case reports. Ocul Immunol Inflamm. 2019;27(4):521–523. doi:10.1080/09273948.2018.1510529.
- Esmaeli-Gutstein B, Winkelman JZ. Uveitis associated with varicella virus vaccine. Am J Ophthalmol. 1999;127(6):733–734. doi:10.1016/S0002-9394(99)00059-8.
- Fraunfelder FW, Suhler EB, Fraunfelder FT. Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol. 2010;29(1):26–29. doi:10.3109/15569520903427717.
- Sood AB, O’Keefe G, Bui D, Jain N. Vogt-Koyanagi-Harada disease associated with hepatitis B vaccination. Ocul Immunol Inflamm. 2019;27(4):524–527. doi:10.1080/09273948.2018.1483520.
- Lee YK, Huang YH. Ocular manifestations after receiving COVID-19 vaccine: a systematic review. Vaccines (Basel). 2021;9(12):1404. doi:10.3390/vaccines9121404.
- Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis. 2021;110:95–97. doi:10.1016/j.ijid.2021.07.035.
- Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(4):753–757. doi:10.1080/09273948.2021.1957123.
- Santovito LS, Pinna G. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report. Inflamm Res. 2021;70(9):931–933. doi:10.1007/s00011-021-01476-9.
- Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. Uveitis after the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association. Retina. 2021;41(12):2462–2471. doi:10.1097/IAE.0000000000003277.
- Alhamazani MA, Alruwaili WS, Alshammri B, Alrashidi S, Almasaud J. A case of recurrent acute anterior uveitis after the administration of COVID-19 vaccine. Cureus. 2022;14(3):e22911. doi:10.7759/cureus.22911.
- Cunningham ET Jr., Pichi F, Mahajan VB, Rosenbaum JT, Zierhut M. Genetics of uveitis. Ocul Immunol Inflamm. 2021;29(2):215–218. doi:10.1080/09273948.2021.1910430.